Ovid Therapeutics Inc. OVID
- OV329 — Drug-Resistant Focal Onset Seizures Phase 2
- OV329 — Tuberous Sclerosis Complex Preclinical
- OV329 — Infantile Spasms Preclinical
Home › Targets › GABA-aminotransferase
GABA-aminotransferase (1 companies · 3 programs)
Companies with an active program directed at GABA-aminotransferase.